DUBLIN, March 30, 2021 \/PRNewswire\/ -- The \"Pharmaceutical Contract Development and Manufacturing Market (Pharmaceutical, Biologics, Active Pharma ingredients, tablet, Parenteral, Oral Liquid, Semi-Solids), End User (Big Pharma, Small Pharma, Generic Pharma, CRO) - Global Forecast to 2025\" report has been added to ResearchAndMarkets.com's offering.<\/p>\n
The global pharmaceutical contract development and manufacturing market are projected to reach USD 146.1 billion by 2025 from USD 100.7 billion in 2020, at a CAGR of 7.7% during the forecast period.<\/p>\n
Market growth is driven mainly by factors such as rising demand for generics, increasing investments in pharmaceutical R&D, and investments in advanced manufacturing technologies by CDMOs. The increasing demand for biological therapies, growing focus on specialty medicines, growth in the nuclear medicines sector, and advancements in cell and gene therapies are also expected to offer market growth opportunities in the coming years.<\/p>\n
The small and medium-sized pharmaceutical companies segment accounted for the highest growth rate in the pharmaceutical contract development and manufacturing market, by end user, during the forecast period<\/p>\n
The pharmaceutical contract development and manufacturing market is segmented into big pharmaceutical companies, small & medium-sized pharmaceutical companies, generic pharmaceutical companies, and other end users. The small and medium-sized pharmaceutical companies segment accounted for the highest growth rate in the pharmaceutical contract development and manufacturing market in 2020. This segment's high growth can be attributed to the increasing number of emerging pharmaceutical companies that lack the in-house capabilities to manufacture and develop complex formulations and drug products.<\/p>\n
Biologics manufacturing services segment accounted for the highest CAGR<\/p>\n
Based on service, the pharmaceutical contract development and manufacturing market is segmented into pharmaceutical manufacturing, biologics manufacturing, and drug development services. In 2020, the biologics manufacturing services segment accounted for the highest growth rate. The major factor driving the growth of this segment is the growing demand for vaccines and biosimilars.<\/p>\n
Asia Pacific: The fastest-growing country in the pharmaceutical contract development and manufacturing market<\/p>\n
The pharmaceutical contract development and manufacturing market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific is projected to register the highest CAGR during the forecast period. This growth can be attributed to factors such as growth in the manufacturing sector, favorable government regulations, growing strategic expansions from leading companies, increasing emphasis on off-patent drugs, and the presence of a highly skilled workforce.<\/p>\n
Market Dynamics<\/p>\n
Drivers<\/p>\n
Opportunities<\/p>\n
Challenges<\/p>\n
Trends<\/p>\n
Value Chain Analysis<\/p>\n
Ecosystem Market Map<\/p>\n
Supply Chain<\/p>\n
Impact of the COVID-19 Pandemic on the Growth of the Pharmaceutical Contract Development and Manufacturing Market<\/p>\n
Regulatory Assessment<\/p>\n
Lists of Companies Profiled in the Report:<\/p>\n
For more information about this report visit https:\/\/www.researchandmarkets.com\/r\/4e33lg<\/a><\/p>\n Media Contact: <\/p>\n Research and Markets Laura Wood, Senior Manager [emailprotected] <\/p>\n For E.S.T Office Hours Call +1-917-300-0470 For U.S.\/CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 <\/p>\n U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716<\/p>\n SOURCE Research and Markets<\/p>\n http:\/\/www.researchandmarkets.com<\/a><\/p>\n <\/p>\n Read the original: DUBLIN, March 30, 2021 \/PRNewswire\/ -- The \"Pharmaceutical Contract Development and Manufacturing Market (Pharmaceutical, Biologics, Active Pharma ingredients, tablet, Parenteral, Oral Liquid, Semi-Solids), End User (Big Pharma, Small Pharma, Generic Pharma, CRO) - Global Forecast to 2025\" report has been added to ResearchAndMarkets.com's offering. The global pharmaceutical contract development and manufacturing market are projected to reach USD 146.1 billion by 2025 from USD 100.7 billion in 2020, at a CAGR of 7.7% during the forecast period Continue reading
\nPharmaceutical Contract Development and Manufacturing Markets, 2025: Increasing Demand for Biological Therapies \/ Growth in the Nuclear Medicine...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"